2008
DOI: 10.1016/j.jcv.2008.09.009
|View full text |Cite
|
Sign up to set email alerts
|

Betapapillomaviruses: Innocent bystanders or causes of skin cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
86
1
2

Year Published

2010
2010
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 90 publications
(94 citation statements)
references
References 91 publications
5
86
1
2
Order By: Relevance
“…To date, the evidence suggesting a causal role of b-HPV in skin cancer has been tainted by: the finding that viral DNA is also found in normal skin, that discovery of the viral genome copy number is usually much less than one viral genome per tumor cell and the fact that viral transcripts have not been identified by high-throughput mRNA sequencing. 19,[54][55][56][57] Alongside the fact that ubiquitous b-HPV DNA carriage does not necessarily indicate active infection, these issues have created and so far maintained a state of uncertainty about the causative role of b-HPVs in non-epidermodysplasia verruciformis skin cancer. Although the present study does not directly demonstrate a causal role of these viruses, the detection of E4 and L1 positivity in (i) actinic keratosis, which are widely regarded to be squamous cell carcinoma precursors or in situ carcinoma, and (ii) the adjacent pathological epithelium of one squamous cell carcinoma and one basal cell carcinoma, clearly shows that b-HPV are actively replicating in the lesional skin of organ transplant recipients and can therefore cooperate with other carcinogenic agents, such as UVB, favoring skin cancer promotion and progression.…”
Section: Modern Pathology (2014) 27 1101-1115mentioning
confidence: 99%
“…To date, the evidence suggesting a causal role of b-HPV in skin cancer has been tainted by: the finding that viral DNA is also found in normal skin, that discovery of the viral genome copy number is usually much less than one viral genome per tumor cell and the fact that viral transcripts have not been identified by high-throughput mRNA sequencing. 19,[54][55][56][57] Alongside the fact that ubiquitous b-HPV DNA carriage does not necessarily indicate active infection, these issues have created and so far maintained a state of uncertainty about the causative role of b-HPVs in non-epidermodysplasia verruciformis skin cancer. Although the present study does not directly demonstrate a causal role of these viruses, the detection of E4 and L1 positivity in (i) actinic keratosis, which are widely regarded to be squamous cell carcinoma precursors or in situ carcinoma, and (ii) the adjacent pathological epithelium of one squamous cell carcinoma and one basal cell carcinoma, clearly shows that b-HPV are actively replicating in the lesional skin of organ transplant recipients and can therefore cooperate with other carcinogenic agents, such as UVB, favoring skin cancer promotion and progression.…”
Section: Modern Pathology (2014) 27 1101-1115mentioning
confidence: 99%
“…This finding is in stark contrast to the predominance of HPV16 in the pathogenesis of cervical carcinoma. The almost ubiquitous presence of betaPV infection in eyebrow hairs, together with very low amounts of betaPV DNA in the skin (42), raises questions about appropriate markers of pathogenic infection and how betaPV could contribute to the development of cutaneous squamous cell carcinoma (43)(44)(45). In contrast to HPV16 and HPV18, the viral load in squamous cell carcinoma seldom reaches the level of 1 viral copy per cell on average (42), indicating that betaPV are not involved in maintenance of the transformed state of the tumor cells.…”
Section: Discussionmentioning
confidence: 99%
“…Mucosal HPV infections tend to clear on their own, but in some cases, latent infection could be established and may persist for years. Cutaneous ␤-genus HPV infections are highly prevalent in the general population and tend to persist (14). Vaccines based on virus-like particles made up of the capsid protein L1 have been developed against HPV-6b, -11, -16, and -18 (Cervarix [GlaxoSmithKline] and Gardasil/Silgard [Merck Research Laboratories]).…”
mentioning
confidence: 99%